SCR-LIP-000626 · Claim · machine-readable JSON →
The main celiac-associated HLA-DQ haplotype is the principal genetic risk determinant for celiac disease, through presentation of gliadin peptides to helper T cells.
General proposition consolidated from 1 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (1)
- The Association of HLA-DQ2 with Celiac Disease (2021) ✓ verified — consistent · review · 2021 · reading confidence: high
“HLA-DQ2 é o principal determinante genético de risco para celíaca. Apresentação de gliadina por DQ2 a células T CD4+ central na patogênese.”
Review describes HLA-DQ2 as the main genetic risk determinant for celiac disease, with DQ2 presentation of gliadin to CD4+ T cells central to its pathogenesis; lipedema is not discussed.
The article reviews the HLA-DQ2–celiac disease association but makes no mention of lipedema; it is on-topic for the celiac/HLA component only and does not test any link to lipedema, so it provides background context rather than direct evide
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000009